Misoprostol for women's health: A review

Obstetrics and Gynecology

Volumn 99, Issue 2, 2002, Pages 316-332

  Blanchard, Kelly ^b   Clark, Shelley ^a   Winikoff, Beverly ^b   Gaines, Gayle ^b   Kabani, Ghazala ^a   Shannon, Caitlin ^b  

^a POPULATION COUNCIL   (South Africa)

^b POPULATION COUNCIL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL;

DELIVERY; DRUG COST; DRUG EFFICACY; DRUG FATALITY; DRUG INDICATION; DRUG INFORMATION; DRUG SAFETY; DRUG SCREENING; DRUG STORAGE; HUMAN; INDUCED ABORTION; LABOR; MORBIDITY; PREGNANCY DISORDER; PRIORITY JOURNAL; REVIEW;

ABORTIFACIENT AGENTS; ABORTION, INDUCED; CERVICAL RIPENING; CLINICAL TRIALS; FEMALE; HUMANS; MISOPROSTOL; OXYTOCICS; PREGNANCY; WOMEN'S HEALTH;

EID: 0036157811     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(01)01701-X     Document Type: Review

References (132)

1. 2 gel (Prepidil gel): A randomized comparison
2. Misoprostol used alone for the termination of early pregnancy: A review of the evidence
3. Induction of labor
4. A randomized comparison of oral misoprostol versus Foley catheter and oxytocin for induction of labor at term
5. Oral or vaginal misoprostol administration for induction of labor: A randomized, double-blind trial
6. Oral misoprostol and intracervical dinoprostone for cervical ripening and labor induction: A randomized comparison
7. A randomized prospective study of misoprostol and dinoprostone for induction of labor
8. A masked randomized comparison of oral and vaginal administration of misoprostol for labor induction
9. Labor induction by vaginal misoprostol in grand multiparous women
10. 2) for cervical ripening and induction of labor in a community hospital
11. Induction of labor with intravaginal misoprostol and intravenous oxytocin for induction of labor
12. Low-dose vaginal misoprostol for induction of labor with a live fetus
13. A randomized comparison between misoprostol and dinoprostone for cervical ripening and labor induction in patients with unfavorable cervices
14. Randomized comparison of oral misoprostol and oxytocin for labor induction in term prelabor membrane rupture
15. Extemporaneous preparation of misoprostol gel for ripening: A randomized trial
16. Randomized comparison of misoprostol and dinoprostone for preinduction cervical ripening and labor induction
17. A randomized comparison of one single dose of vaginal 50 μg misoprostol with 3 mg dinoprostone in pre-induction cervical ripening
18. Induction of labor by vaginal misoprostol in patients with previous cesarean delivery
19. 1 methyl analogue) to expedite delivery in severe preeclampsia remote from term
20. A double-blind randomized trial of two dose regimens of misoprostol for cervical ripening and labor induction
21. Randomised comparative study of induced labor with oxytocin and misoprostol in prolonged pregnancies
22. A comparative trial of labor induction with misoprostol versus oxytocin
23. 1 analog misoprostol for labor induction
24. Intravaginal misoprostol as a cervical ripening agent
25. Intravaginal misoprostol versus dinoprostone as cervical ripening and labor-inducing agents
26. 2 gel for preinduction cervical ripening
27. 2 gel for ripening of unfavorable cervix and labor induction
28. Oral misoprostol vs. placebo in the management of prelabor rupture of membranes at term
29. 2 in term pregnancy
30. 2, but is it associated with more risk?
31. A randomized trial of misoprostol and oxytocin for induction of labor: Safety and efficacy
32. A randomised double-blind study of vaginal misoprostol vs dinoprostone for cervical ripening and labour induction in prolonged pregnancy
33. Intracervical misoprostol as an effective method of labor induction at term
34. Misoprostol as a labor induction agent
35. Vaginal misoprostol for induction of labor: A randomized controlled trial
36. Comparison between vaginal misoprostol and cervical dinoprostone for cervical ripening and labor induction
37. Cervical priming with oral misoprostol in pre-labor rupture of membranes at term
38. Labour characteristics and uterine activity: Misoprostol compared with oxytocin in women at term with prelabour rupture of membranes
39. Randomized comparison between intravaginal misoprostol and dinoprostone for cervical ripening and induction of labor
40. Induction of labor with intravaginal misoprostol versus intracervical dinoprostone
41. Cervical ripening: A randomized comparison between intravaginal misoprostol and intracervical balloon catheter combined with intravaginal dinoprostone
42. Induction of labor with intravaginal administration of misoprostol
43. 1 misoprostol compared with dinoprostone vaginal insert: A randomized trial
44. Oral administration of misoprostol for labor induction: A randomized controlled trial
45. Labor induction with intravaginal misoprostol in term premature rupture of membranes: A randomized study
46. 1 methyl analogue misoprostol versus oxytocin: A randomized trial
47. A comparison between 25 μg and 50 μg of intravaginal misoprostol for labor induction
48. Comparison of intracervical and intravaginal misoprostol for cervical ripening and labour induction in patients with an unfavourable cervix
49. 1 methyl analogue misoprostol: A randomized controlled trial
50. 2 to induce labor
51. Oral or vaginal misoprostol for induction of labour
52. 2 gel for induction of labor at term
53. A randomized trial of misoprostol and extra-amniotic saline infusion for cervical ripening and labor induction
54. Cervical ripening in the third trimester of pregnancy with intravaginal misoprostol: A double-blind, randomized, placebo-controlled study
55. Oral administration of misoprostol for labor induction: A randomized controlled trial
56. Induction of labor with misoprostol for premature rupture of membranes beyond thirty-six weeks' gestation
57. A randomized comparison of oral and intravaginal misoprostol for labor induction
58. 2 gel for preinduction cervical ripening and labor induction
59. A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction
60. A comparison of intermittent vaginal administration of misoprostol with continuous dinoprostone for cervical ripening and labor induction
61. A comparison of orally administered misoprostol with vaginally administered misoprostol for cervical ripening and labor induction
62. Misoprostol for cervical ripening and labor induction. A meta-analysis
63. Vaginal misoprostol for cervical ripening and labour induction in late pregnancy (Cochrane review)
64. Misoprostol for induction of labor: A systematic review
65. Labor induction with misoprostol
66. Uterine rupture associated with the use of misoprostol in the gravid patient with a previous cesarean section
67. Use of oral misoprostol in the prevention of postpartum haemorrhage
68. Rectal misoprostol in the prevention of postpartum hemorrhage: A placebo-controlled trial
69. A randomised placebo controlled trial of oral misoprostol in the third stage of labour
70. Oral misoprostol for third stage of labor: A randomized placebo-controlled trial
71. Randomized comparison of rectal misoprostol with syntometrine for management of third stage of labor
72. Misoprostol compared with methylergometrine for the prevention of postpartum hemorrhage: A double-blind randomised trial
73. A randomized clinical trial comparing oral misoprostol with synthetic oxytocin or syntometrine in the third stage of labor
74. Misoprostol dose-related shivering and pyrexia in the third stage of labour
75. The misoprostol third stage of labour study: A randomized controlled comparison between orally administered misoprostol and standard management
76. A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour
77. A multicentre randomized controlled trial of oral misoprostol and i.m. syntometrine in the management of the third stage of labour
78. Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: A descriptive study
79. Medical management of miscarriage: Non-surgical uterine evacuation of incomplete and inevitable spontaneous abortion
80. Misoprostol in the management of spontaneous abortion
81. Randomised clinical trial of medical evacuation and surgical curettage for incomplete miscarriage
82. A medical approach to management of spontaneous abortion using misoprostol. Extending misoprostol treatment to a maximum of 48 hours can further improve evacuation of retained products of conception in spontaneous abortion
83. Spontaneous abortion: A randomized, controlled trial comparing surgical evacuation with conservative management using misoprostol
84. Misoprostol in the management of missed abortion
85. Misoprostol for medical evacuation of early pregnancy failure
86. Intravaginal misoprostol for medical evacuation of first trimester missed abortion
87. Vaginal misoprostol alone is effective in the treatment of missed abortion
88. Medical management of non-viable early first trimester pregnancy
89. Vaginal misoprostol in the management of first-trimester missed abortions
90. A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure
91. Induction of labor with intravaginal misoprostol in intrauterine fetal death
92. Vaginal misoprostol as an alternative to oxytocin for induction of labor in women with late fetal death
93. Induction of labor with intravaginal misoprostol in the second and third trimester of pregnancy
94. Comparative study of intravaginal misoprostol with gemeprost as an abortifacient in second trimester missed abortion
95. Application of vaginal misoprostol before cervical dilatation to facilitate first-trimester pregnancy interruption
96. 1 analogues, misoprostol and gemeprost
97. Oral misoprostol versus placebo for cervical dilatation before vacuum aspiration in first trimester pregnancy
98. Oral misoprostol versus vaginal gemeprost for cervical dilatation prior to vacuum aspiration in women in the sixth to twelfth week of gestation
99. Is misoprostol the drug of choice for induced cervical ripening in early pregnancy termination?
100. A randomized comparison of oral and vaginal misoprostol for cervical priming before suction termination of pregnancy
101. Effect of vaginal misoprostol application for cervical softening in pregnancy interruption before ten weeks of gestation
102. Oral misoprostol versus mifepristone for cervical dilatation before vacuum aspiration in first trimester nulliparous pregnancy: A double blind prospective randomised study
103. A comparative study using two dose regimens (200 μg or 400 μg) of vaginal misoprostol for pre-operative cervical dilatation in first trimester nulliparae
104. Preoperative cervical softening before first trimester legal abortion by mifepristone and misoprostol - A double-blind, randomized, clinical biochemical and immunohistochemical study
105. Vaginal dinoprostone versus oral misoprostol for predilation of the cervix in first trimester surgical abortion
106. Randomized trial to determine optimal dose of vaginal misoprostol for preabortion cervical priming
107. A randomized controlled trial of laminaria, oral misoprostol, and vaginal misoprostol before abortion
108. Does an acidic medium enhance the efficacy of vaginal misoprostol for pre-abortion cervical ripening?
109. Evacuation interval after vaginal misoprostol for preabortion cervical priming: A randomized trial
110. Vaginal misoprostol for pre-abortion cervical priming: Is there an optimal evacuation time interval?
111. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: A randomized, controlled study
112. Randomised controlled trial of the efficacy of misoprostol used as a cervical ripening agent prior to termination of pregnancy in the first trimester
113. Misoprostol and pregnancy
114. The effectiveness of intravaginal misoprostol (Cytotec) in inducing abortion after eleven weeks of pregnancy
115. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy
116. A comparison of misoprostol with and without laminaria tents for induction of second-trimester abortion
117. Second trimester pregnancy termination including fetal death: Comparison of five different methods
118. Midtrimester termination of complicated pregnancy with oral misoprostol
119. A comparison between two doses of intravaginal misoprostol and gemeprost for induction of second-trimester abortion
120. Termination of second-trimester pregnancy with intracervicovaginal misoprostol
121. Efficacy of intracervicovaginal misoprostol in second-trimester pregnancy termination: A comparison between live and dead fetuses
122. Vaginal misoprostol for early second-trimester abortion
123. Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: A randomized controlled trial
124. Second-trimester termination of pregnancy by extra-amniotic prostaglandin F2alpha or endocervical misoprostol. A comparative study
125. Second trimester abortion using intravaginal misoprostol
126. Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy: A randomized trial
127. 2 for second trimester pregnancy termination
128. A comparison of two dosing regimens of intravaginal misoprostol for second-trimester pregnancy termination
129. Vaginal misoprostol compared to oral misoprostol in termination of second trimester pregnancy
130. WHO multicentre randomized trial of misoprostol in the management of the third stage of labour